SCHEMBL4577231

SCHEMBL4577231

CC(C)(C)N1CC(C(=O)N2CCC(c3ccc(F)cc3CC(N)=O)CC2)C(c2ccc(F)cc2F)C1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRCP P42785 16/20 0.63
MC4R P32245 4/20 0.60
MC3R P41968 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4577262 0.87 PRCP (0.58) PRCPMC4RMC3R
SCHEMBL6240843 0.86 MC4R (0.67) PRCPMC4RMC3R
SCHEMBL6240837 0.86 MC4R (0.67) PRCPMC4RMC3R
SCHEMBL5061493 0.85 MC4R (0.57) PRCPMC4RMC3R
SCHEMBL5061498 0.85 PRCP (0.58) PRCPMC4RMC3R
SCHEMBL5617401 0.85 MC4R (0.72) PRCPMC4RMC3R
SCHEMBL4577263 0.84 MC4R (0.63) PRCPMC4RMC3R
SCHEMBL5227884 0.84 MC4R (0.67) PRCPMC4RMC3R
SCHEMBL4576351 0.83 MC4R (0.59) PRCPMC4RMC3R
SCHEMBL5608656 0.83 MC4R (0.68) PRCPMC4RMC3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534074-A4 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY MERCK & CO INC (US) 2008-01-09 EP claimed
EP-1534074-A2 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY Merck & Co., Inc. (US) 2005-06-01 EP claimed
WO-2004009015-A2 COMBINATION THERAPY FOR THE TREATMENT OF OBESITY MERCK & CO., INC. (US) 2004-01-29 WO claimed